Diego Díaz García, Medical Oncologist, CEO and Founder of CánCare, shared a post on X about a paper by Yibei Wang et al. published in Nature Reviews Clinical Oncology:
“Immunotherapy for advanced-stage SqNSCLC: the state of the art.
Comprehensive overview of current immunotherapeutic approaches, unresolved challenges and emerging strategies.”
Authors: Yibei Wang, Mohammed Safi, Fred Hirsch, Shun Lu, Solange Peters, Ramaswamy Govindan, Rafael Rosell, Keunchil Park, Jianjun Zhang.
More posts featuring Diego Díaz García.
